The Floodlight MS app, used to track disease progression in people with multiple sclerosis, has been deemed cost-effective in ...
Experts in Australia and New Zealand have published the first consensus guidelines for the care of adults with MS in those ...
TG Therapeutics to use MaxCyte’s Flow Electroporation® technology and ExPERTâ„¢ platform to support the development and commercialization of azer-cel, its allogeneic CD19 CAR T cell therapy program, for ...
WHEN life gave Lina Nielsen lemons, she sprinted straight to the Olympics. The 28-year-old was diagnosed with multiple sclerosis at 17 years old, leaving her terrified of disability. Doctors gave ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results